PCM
ABBV icon

Pointe Capital Management’s AbbVie ABBV Stock Holding History

Pointe Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-680
Closed -$108K – 151
2023
Q1 		$108K Buy
+680
New +$104K 0.08% 182
2017
Q1 		– Sell
-4,157
Closed -$260K – 147
2016
Q4 		$260K Buy
+4,157
New +$254K 0.15% 115

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pointe Capital Management's ABBV Position: Q2 2023 in Review

Pointe Capital Management sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 680 shares — an estimated $108K sold.

Pointe Capital Management first reported a position in ABBV in Q4 2016 and held it in 2 quarters. The position peaked at $260K in Q4 2016. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Pointe Capital Management reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • Pointe Capital Management sold 680 AbbVie shares in Q2 2023, an estimated $108K.
  • Pointe Capital Management first reported a position in AbbVie in Q4 2016 and held it in 2 quarters.
  • Pointe Capital Management's AbbVie position peaked at $260K in Q4 2016.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Pointe Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.